Permethrin and Stelara drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Permethrin (permethrin) and Stelara (ustekinumab). Common drug interactions include body temperature decreased among females and psoriatic arthropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Permethrin and Stelara. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Permethrin?

Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.



On Jul, 17, 2026

23 people who take Permethrin and Stelara together, and have interactions are studied.

Permethrin and Stelara drug interactions.

What are the common drug interactions of Permethrin and Stelara, by gender? *:

female:

  1. Body temperature decreased
  2. Burning sensation
  3. Cellulitis (infection under the skin)
  4. Drug ineffective
  5. Dry skin
  6. Infection
  7. Pain
  8. Pruritus (severe itching of the skin)
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Tooth abscess (pus formation in tooth)

male:

  1. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  2. Diarrhoea
  3. Anal haemorrhage
  4. Blood pressure increased
  5. Cellulitis (infection under the skin)
  6. Depression
  7. Emotional distress
  8. Joint range of motion decreased (disease of joint movement)
  9. Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
  10. Rheumatoid factor increased

What are the common drug interactions of Permethrin and Stelara, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Drug ineffective
  3. Dry skin
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Hidradenitis (chronic disease of a type of sweat gland)
  6. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  7. Abdominal discomfort
  8. Fatigue (feeling of tiredness)
  9. Nausea (feeling of having an urge to vomit)
  10. Skin haemorrhage (bleeding into skin)

50-59:

  1. Blood pressure increased
  2. Cellulitis (infection under the skin)
  3. Depression
  4. Emotional distress
  5. Joint range of motion decreased (disease of joint movement)
  6. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  7. Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
  8. Rheumatoid factor increased
  9. Gait disturbance
  10. Nail disorder (disease of nail)

60+:

  1. Infection
  2. Body temperature decreased
  3. Wound
  4. Acarodermatitis (skin inflammation caused by mites (acarids))
  5. Hypersensitivity
  6. Insomnia (sleeplessness)
  7. Alopecia (absence of hair from areas of the body)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Panic attack
  10. Weight decreased

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 13.04%
  2. Pain: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Permethrin and Stelara?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Permethrin and Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Permethrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Permethrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stelara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on permethrin and ustekinumab (the active ingredients of Permethrin and Stelara, respectively), and Permethrin and Stelara (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: